Vanda Pharmaceuticals (VNDA) Other Non-Current Assets (2011 - 2015)
Vanda Pharmaceuticals recorded quarterly Other Non-Current Assets of $813000.0 in Q3 2015, little changed quarter-over-quarter from $813000.0 in Q2 2015, and up 3.57% year-over-year from $785000.0 in Q3 2014.
Vanda Pharmaceuticals' Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $813000.0 for Q3 2015.
- In Q3 2015, Other Non-Current Assets rose 3.57% year-over-year to $813000.0; the TTM figure through Sep 2015 stood at $813000.0 (up 3.57% YoY), while the FY2014 annual figure was $813000.0, up 62.6% from the prior year.
- Other Non-Current Assets came in at $813000.0 for Q3 2015 at Vanda Pharmaceuticals, roughly flat from $813000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.0 million in Q3 2011 to a low of $84000.0 in Q1 2012.
- A 5-year average of $682277.8 and a median of $692500.0 in 2011 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets slumped 41.75% in 2012 and surged 614.29% in 2013, its largest moves.
- Vanda Pharmaceuticals' Other Non-Current Assets stood at $600000.0 in 2011, then changed by 0.0% to $600000.0 in 2012, then declined by 16.67% to $500000.0 in 2013, then surged by 62.6% to $813000.0 in 2014, then changed by 0.0% to $813000.0 in 2015.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $813000.0, $813000.0, and $813000.0 for Q3 2015, Q2 2015, and Q1 2015 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 813,000.00 |
| Jun 30, 2015 | 813,000.00 |
| Mar 31, 2015 | 813,000.00 |
| Dec 31, 2014 | 813,000.00 |
| Sep 30, 2014 | 785,000.00 |
| Jun 30, 2014 | 785,000.00 |
| Mar 31, 2014 | 785,000.00 |
| Dec 31, 2013 | 500,000.00 |
| Sep 30, 2013 | 500,000.00 |
| Jun 30, 2013 | 600,000.00 |
| Mar 31, 2013 | 600,000.00 |
| Dec 31, 2012 | 600,000.00 |
| Sep 30, 2012 | 600,000.00 |
| Jun 30, 2012 | 1.03 Mn |
| Mar 31, 2012 | 84,000.00 |
| Dec 31, 2011 | 600,000.00 |
| Sep 30, 2011 | 1.03 Mn |
| Jun 30, 2011 | 530,000.00 |